These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23316301)

  • 1. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
    Stamler J; Neaton JD; Cohen JD; Cutler J; Eberly L; Grandits G; Kuller LH; Ockene J; Prineas R;
    J Am Heart Assoc; 2012 Oct; 1(5):e003640. PubMed ID: 23316301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1986 Jul; 58(1):1-13. PubMed ID: 2873741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
    Howard BV; Van Horn L; Hsia J; Manson JE; Stefanick ML; Wassertheil-Smoller S; Kuller LH; LaCroix AZ; Langer RD; Lasser NL; Lewis CE; Limacher MC; Margolis KL; Mysiw WJ; Ockene JK; Parker LM; Perri MG; Phillips L; Prentice RL; Robbins J; Rossouw JE; Sarto GE; Schatz IJ; Snetselaar LG; Stevens VJ; Tinker LF; Trevisan M; Vitolins MZ; Anderson GL; Assaf AR; Bassford T; Beresford SA; Black HR; Brunner RL; Brzyski RG; Caan B; Chlebowski RT; Gass M; Granek I; Greenland P; Hays J; Heber D; Heiss G; Hendrix SL; Hubbell FA; Johnson KC; Kotchen JM
    JAMA; 2006 Feb; 295(6):655-66. PubMed ID: 16467234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.
    Perna L; Schöttker B; Holleczek B; Brenner H
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4908-15. PubMed ID: 24106288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
    Circulation; 1990 Nov; 82(5):1616-28. PubMed ID: 2225366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prehypertension and incident acute coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Glasser SP; Khodneva Y; Lackland DT; Prineas R; Safford MM
    Am J Hypertens; 2014 Feb; 27(2):245-51. PubMed ID: 24190905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
    Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
    Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial.
    Kotalik A; Eaton A; Lian Q; Serrano C; Connett J; Neaton JD
    Clin Trials; 2019 Dec; 16(6):626-634. PubMed ID: 31389723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.
    Circulation; 1996 Sep; 94(5):946-51. PubMed ID: 8790030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial.
    Gump BB; Matthews KA; Eberly LE; Chang YF;
    Stroke; 2005 Jan; 36(1):98-102. PubMed ID: 15569872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.
    JAMA; 1982 Sep; 248(12):1465-77. PubMed ID: 7050440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1985 Jan; 55(1):1-15. PubMed ID: 3880997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity.
    Stamler J; Daviglus ML; Garside DB; Dyer AR; Greenland P; Neaton JD
    JAMA; 2000 Jul; 284(3):311-8. PubMed ID: 10891962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Prev Med; 1986 May; 15(3):254-73. PubMed ID: 3749007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study.
    Bachmann JM; Willis BL; Ayers CR; Khera A; Berry JD
    Circulation; 2012 Jun; 125(25):3092-8. PubMed ID: 22623718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
    Tunstall-Pedoe H; Kuulasmaa K; Amouyel P; Arveiler D; Rajakangas AM; Pajak A
    Circulation; 1994 Jul; 90(1):583-612. PubMed ID: 8026046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE
    J Am Heart Assoc; 2019 Oct; 8(19):e013543. PubMed ID: 31567003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.
    Shaten BJ; Kuller LH; Kjelsberg MO; Stamler J; Ockene JK; Cutler JA; Cohen JD
    Ann Epidemiol; 1997 Feb; 7(2):125-36. PubMed ID: 9099400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.